Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Glycaemic control in patients with type 1 diabetes is slightly better
during continuous insulin infusion than during optimised insulin
injection treatment. Pickup and colleagues (p 705) performed a
meta-analysis of 12 randomised controlled trials involving 301 patients
with type 1 diabetes allocated to insulin infusion and 299 allocated to
insulin injection. They conclude that continuous subcutaneous insulin
infusion is an effective form of intensive insulin that should lower
the risk of microvascular complications. However, insulin pump
treatment is unnecessary for most people with type 1 diabetes and
should be reserved for those experiencing problems with optimised
insulin injections.